Genome Therapeutics Corporation (GENE) - Earnings Reports, Stock Quote and Stock Chart
|
|
| Earnings Reports for GENE - Genome Therapeutics Corporation | |||||||||||||
| list date | symbol | list price | wl | rt | er | sr | pes | eps | sales (m) | epc | spc | group | avg vol |
| 05/11/04 | GENE | 4.96 | EX1 | 5 | 9 | -35 | -.14/-.37 | 1.8 / 2.7 | - | -36+ | MEG | 856,000 | |
| 03/08/04 | GENE | 6.04 | EX1 | 5 | 10 | -201 | -.03/-.38 | 1.7 / 5.8 | - | -70- | MEG | 731,000 | |
| 11/12/03 | GENE | 2.82 | EX1 | 1 | 9 | -13 | -.22/-.44 | 2.87 / 5.0 | - | -43+ | MEG | 436,000 | |
| 08/13/03 | GENE | 2.88 | E | 1 | 9 | -8 | -.35/-.36 | 1.7 / 5.9 | - | -71- | MEG | 143,000 | |
| 05/14/03 | gene | 2.30 | E | 1 | 8 | -6 | -.37/-.30 | 2.7 / 6.1 | - | -56- | MEG | 176,000 | |
| 03/05/03 | gene | 1.56 | E | 1 | 1 | -4 | -.38/-.35 | 5.8 / 8.8 | - | -34- | MEG | 63,000 | |
| 11/13/02 | gene | 1.63 | E | 1 | 1 | -4 | -.44/-.18 | 5.0 / 7.3 | - | -32+ | MEG | 63,000 | |
| 08/14/02 | gene | 1.85 | E | 1 | 1 | -5 | -.36/.09 | 5.9 / 11.3 | - | -47- | MEG | 63,000 | |
| 05/14/02 | gene | 3.42 | E | 0 | 1 | -11 | -.30/nil | 6.1 / 8.0 | - | -24- | MEG | 103,000 | |
| 03/19/02 | gene | 5.84 | EX1 | 0 | 2 | -17 | -.35/-.11 | 8.8 / 6.3 | - | +40+ | MEG | 122,000 | |
| 11/09/01 | gene | 7.31 | EX1 | 3 | 3 | -41 | -.18/-.06 | 7.3 / 5.9 | - | +25+ | MEG | 229,000 | |
| 07/10/01 | gene | 12.67 | E | 0 | 9 | -115 | -.11/-.04 | 6.4 / 6.4 | - | -1- | MEG | 1,241,000 | |
| 04/11/01 | gene | 5.83 | EX1 | 0 | 2 | -292 | -.02/-nil | 8.1 / 7.8 | - | +5+ | MEG | 245,000 | |
| 01/10/01 | gene | 6.75 | E | 2 | 1 | -96 | -.07/-.01 | na / na | - | -7- | MEG | 362,000 | |
| 10/20/00 | gene | 16.00 | E | 2 | 9 | -200 | -.08/-.05 | na / na | - | -2 | MEG | 475,000 | |
| 07/12/00 | GENE | 30.31 | E | 5 | 10 | -758 | -.04/-.09 | na / na | - | +3- | MEG | 1,368,000 | |
| 03/23/00 | GENE | 35.68 | EX1 | 5 | 10 | -9913 | -.0036/-.07 | na / na | - | +22+ | MEG | 1,871,000 | |
| 01/07/00 | GENE | 15.12 | EX1 | 5 | 10 | -1513 | -.01/-.13 | na / na | - | +18+ | MEG | 739,000 | |
| • - indicates a break in earnings coverage |
| Displaying records 1 through 18 of 18 total records. |
